BMC Nephrology · 2011 · 10 citations · 12 references
MedicineImmunologyNephrologyAutoimmunityImmunopathologyRenal PathologyAutoantibodiesGlomerular DiseasesHumoral ImmunityImmune-mediated Renal DiseaseRenal DiseaseRenal ImmunopathologyAnti-neutrophil Cytoplasmic AntibodiesAnti-neutrophil Cytoplasmic Antibody TestingAntibody-mediated Glomerular InjuryAutoantigen IdentificationAutoimmune Glomerular InjuryDisease Activity MeasurementGlomerular Basement Membrane AntigensSmall Vessel Nephropathy
BACKGROUND: Pulmonary-renal syndrome associated with anti-glomerular basement membrane (GBM) antibodies, also known as Goodpasture's syndrome, is a rare but acute and life-threatening condition. One third of patients presenting as anti-GBM antibody positive pulmonary-renal syndrome or rapidly progressive glomerulonephritis are also tested positive for anti-neutrophil cytoplasmic antibodies (ANCA). Whilst anti-GBM disease is considered a non-relapsing condition, the long-term course of double-positive patients is less predictable. CASE PRESENTATION: We report a patient with such dual positivity, who presented with pulmonary hemorrhage, crescentic glomerulonephritis and membranous nephropathy. Plasmapheresis in combination with immunosuppressive therapy led to a rapid remission but the disease relapsed after two years. The serum of the patient was tested positive for antibodies to human lysosomal membrane protein 2 (hLAMP2), a novel autoantigen in patients with active small-vessel vasculitis (SVV). The anti-hLAMP2 antibody levels correlated positively with clinical disease activity in this patient. CONCLUSION: We hypothesize that this antibody may indicate a clinical course similar to ANCA-associated vasculitis in double-positive patients. However, this needs to be confirmed on comprehensive patient cohorts.
12
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain, Markus Exner, Ricarda Brandes et al. · Nature Medicine · 2008 · 456 citations · Full text
Medicine, Immunology, Pathology +14
Clinical features and outcome of patients with both ANCA and anti-GBM antibodies
Jeremy Levy, Tarig Hammad, Anne Coulthart et al. · Kidney International · 2004 · 358 citations · Full text
Life Sciences, Immunology, Oncology +14